FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products.
about
Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritisRole of advanced glycation end products in cellular signalingStabilin-2 modulates the efficiency of myoblast fusion during myogenic differentiation and muscle regeneration.Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivoFucoidan as a marine anticancer agent in preclinical developmentApoptotic cell recognition receptors and scavenger receptors.Degradation of oxidative stress-induced denatured albumin in rat liver endothelial cells.N-Glycans on the link domain of human HARE/Stabilin-2 are needed for hyaluronan binding to purified ecto-domain, but not for cellular endocytosis of hyaluronanA hyaluronan receptor for endocytosis (HARE) link domain N-glycan is required for extracellular signal-regulated kinase (ERK) and nuclear factor-κB (NF-κB) signaling in response to the uptake of hyaluronan but not heparin, dermatan sulfate, or acetyGenome resequencing and bioinformatic analysis of SNP containing candidate genes in the autoimmune vitiligo Smyth line chicken model.S100A11, a dual growth regulator of epidermal keratinocytes.Oligo-guanosine nucleotide induces neuropilin-1 internalization in endothelial cells and inhibits angiogenesisStabilin-1 localizes to endosomes and the trans-Golgi network in human macrophages and interacts with GGA adaptors.Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE).Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategiesTissue-specific splice variants of HARE/Stabilin-2 are expressed in bone marrow, lymph node, and spleen.The Dynamics of Oxidized LDL during Atherogenesis.Identification of aortic arch-specific quantitative trait loci for atherosclerosis by an intercross of DBA/2J and 129S6 apolipoprotein E-deficient miceHARE-Mediated Endocytosis of Hyaluronan and Heparin Is Targeted by Different Subsets of Three Endocytic Motifs.Extracellular low pH modulates phosphatidylserine-dependent phagocytosis in macrophages by increasing stabilin-1 expressionThematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors.Activation of ERK and NF-κB during HARE-Mediated Heparin Uptake Require Only One of the Four Endocytic Motifs.Probing structural selectivity of synthetic heparin binding to Stabilin protein receptorsC-type natriuretic peptide protects the retinal pigment epithelium against advanced glycation end product-induced barrier dysfunction.Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3AStabilin-1, a homeostatic scavenger receptor with multiple functions.Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver.The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E.Lymphocyte recruitment to the liver: molecular insights into the pathogenesis of liver injury and hepatitis.Purification, crystallization and preliminary X-ray diffraction of wild-type and mutant recombinant human transforming growth factor beta-induced protein (TGFBIp).Hyaluronic acid receptor for endocytosis (HARE)-mediated endocytosis of hyaluronan, heparin, dermatan sulfate, and acetylated low density lipoprotein (AcLDL), but not chondroitin sulfate types A, C, D, or E, activates NF-κB-regulated gene expressionAntisense Oligonucleotides: Treatment Strategies and Cellular Internalization.The scavenger endothelial cell: a new player in homeostasis and immunity.Liver Sinusoidal Endothelial Cells.The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparinStabilin-2 mediates homophilic cell-cell interactions via its FAS1 domains.The cytoplasmic domain of the hyaluronan receptor for endocytosis (HARE) contains multiple endocytic motifs targeting coated pit-mediated internalizationInvolvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy.Statins decrease vascular epithelial growth factor expression via down-regulation of receptor for advanced glycation end-productsDNAX-activating protein 10 (DAP10) membrane adaptor associates with receptor for advanced glycation end products (RAGE) and modulates the RAGE-triggered signaling pathway in human keratinocytes
P2860
Q24684208-61986C21-CADC-4D5E-A663-C822F535AE3DQ27003423-B3902D09-9236-4A73-8A6A-DDF729138488Q27325652-825D468F-2ED1-4DBF-BE55-A3A58058DB52Q28265835-4FDAE2C7-EB0C-4927-9DE9-03EF6378A597Q28397061-B5D15A9D-AFE1-47BB-8B0C-EFA083B7F344Q30277892-F4F15620-4697-4F5D-88D9-DEE1CE676D5AQ33214716-8D5CA6B6-D547-41D7-B927-F79D11ECC44FQ33955772-31523DED-A97F-46BC-BB9C-F5C9D1995EF9Q34070308-427D51CD-D79F-4025-B1DA-D4A315077DAAQ34123644-163DEB52-BA74-4518-A732-C5008BCF3B26Q34140211-79E3015A-FD7A-4873-B6F9-93B35F547BFEQ34282386-1973A6CD-422A-46BD-8EC8-469AF68CE15CQ34345581-7EA5EB81-F225-46CE-9A93-BB07D805C10DQ34587232-632FFBBA-B2C6-4A3E-84F4-10AE173B8422Q34728267-5143D6BC-3E49-4F19-BA94-18B582B0600DQ34772053-5D385446-F5A5-4045-B7F5-4825A64A8D07Q35024665-ACF6B162-698B-41F3-BF4D-FAAC518EF068Q35092338-75BC19C9-2F97-4A4A-9DEE-8F450A2A8D85Q35324915-853BE760-D792-4273-AC38-AF51B9757960Q35879565-FFA23519-4F8B-421D-B885-24581C1A050EQ35952837-C1F9B077-0DB7-4AAB-87CE-BA69260D1C5DQ35995906-24202E58-ACDD-47F4-9AD9-CE7F4AC6AE22Q36033096-FE3119D4-BD61-42AE-996E-8821E9DA6049Q36497572-8F14FBBA-AD90-41C0-AAD2-83F54106F125Q36528775-4482B8A3-0AF2-4A8B-84B1-5CFCBEA19D08Q36600426-C02B1CB1-E871-46DA-AF6D-C76331F82752Q36775577-323D7BA8-F35A-4C6F-94E6-550D35938F63Q36922376-C4653B7E-0710-4E36-A6FD-A59B793641CCQ37087991-E03EC5FC-1206-4481-A369-9D99D248F7F2Q37115528-882730C3-86EA-4CBF-A128-B08252A4067EQ37488558-F9EAA428-DC7D-4549-B7A4-5B944675D2ADQ37733136-CD7C0CFF-ECA8-44E2-AB02-36C65468A808Q38053123-E1C3429F-F523-4877-9292-D48AD9C261ADQ38596697-120BCD4D-8E26-4CC0-8F4F-EA93F70D610EQ39143125-98EE1E0D-58E8-4C29-BAC6-44A4801DA163Q39867279-55C78A3E-02F1-4105-BD43-4035AED6B4F8Q41177184-8073D4C1-E060-4809-8329-4064154CB1DBQ41789363-9F2ED3C2-ADB7-47E5-8AF0-0BCED3221CC7Q41923200-3D867EC0-409F-4338-9A69-59DE6DE98CB1Q42266144-1B5A1073-C014-4CE7-9696-32A0273F1709
P2860
FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products.
@ast
FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products.
@en
type
label
FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products.
@ast
FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products.
@en
prefLabel
FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products.
@ast
FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products.
@en
P2093
P2860
P356
P1476
FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products
@en
P2093
Hideki Adachi
Hiroaki Okazaki
Hitoshi Shimano
Jun-ichi Osuga
Ken Ohashi
Masafumi Tsujimoto
Motohiro Sekiya
Ryozo Nagai
Sachiko Tomita
Satoshi Kimura
P2860
P304
12613-12617
P356
10.1074/JBC.M210211200
P407
P50
P577
2002-12-06T00:00:00Z